CTOR
Price
$1.90
Change
+$0.02 (+1.07%)
Updated
Sep 5, 04:58 PM (EDT)
Capitalization
147.34M
PRFX
Price
$1.43
Change
-$0.19 (-11.73%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
2.86M
68 days until earnings call
Interact to see
Advertisement

CTOR vs PRFX

Header iconCTOR vs PRFX Comparison
Open Charts CTOR vs PRFXBanner chart's image
Citius Oncology
Price$1.90
Change+$0.02 (+1.07%)
Volume$100
Capitalization147.34M
PainReform
Price$1.43
Change-$0.19 (-11.73%)
Volume$813
Capitalization2.86M
CTOR vs PRFX Comparison Chart in %
Loading...
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTOR vs. PRFX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CTOR: $1.87 vs. PRFX: $1.63)
Brand notoriety: CTOR and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 11% vs. PRFX: 63%
Market capitalization -- CTOR: $147.34M vs. PRFX: $2.86M
CTOR [@Pharmaceuticals: Generic] is valued at $147.34M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $2.86M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • CTOR’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, CTOR is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 3 TA indicator(s) are bullish while PRFX’s TA Score has 4 bullish TA indicator(s).

  • CTOR’s TA Score: 3 bullish, 5 bearish.
  • PRFX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CTOR and PRFX are a bad buy in the short-term.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а -11.79% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was +10.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was +85.54%.

Reported Earning Dates

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTOR($147M) has a higher market cap than PRFX($2.86M). CTOR YTD gains are higher at: 62.609 vs. PRFX (-51.565). PRFX has less debt than CTOR: PRFX (59K) vs CTOR (3.8M).
CTORPRFXCTOR / PRFX
Capitalization147M2.86M5,142%
EBITDA-25.48MN/A-
Gain YTD62.609-51.565-121%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash112N/A-
Total Debt3.8M59K6,441%
TECHNICAL ANALYSIS
Technical Analysis
CTORPRFX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
27%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
28%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGSOY10.170.10
+0.99%
SGS SA
MSVB16.460.12
+0.73%
Mid-Southern Bancorp, Inc.
JSGCF12.00N/A
N/A
LIXIL Corp.
JCRRF5.00N/A
N/A
JCR PHARMACEUTICALS CO LTD.
BPPTU0.13-0.01
-5.45%
BP Prudhoe Bay Royalty Trust

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and TKNO have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-5.08%
TKNO - CTOR
15%
Poorly correlated
-0.24%
UTHR - CTOR
10%
Poorly correlated
-2.80%
ALVO - CTOR
5%
Poorly correlated
+1.13%
PRFX - CTOR
4%
Poorly correlated
+15.25%
SHPH - CTOR
4%
Poorly correlated
-5.52%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and BHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and BHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
+15.25%
BHC - PRFX
26%
Poorly correlated
-1.90%
AMRX - PRFX
24%
Poorly correlated
+0.10%
EVOK - PRFX
24%
Poorly correlated
-0.19%
ZTS - PRFX
22%
Poorly correlated
+0.51%
PBH - PRFX
21%
Poorly correlated
-0.24%
More